Recognition of the link between non‐alcoholic fatty liver disease (NAFLD) and
cardiovascular disease (CVD) has boosted research in this area. The main objective of this …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to
the global obesity epidemic. NAFLD comprises a systemic metabolic disease accompanied …

A number of recent reports have raised alarm about the link between nonalcoholic fatty liver
disease (NAFLD) and cardiovascular risk [1▪▪, 2▪, 3, 4]. Worry appears justified as the …

The natural history of non-alcoholic fatty liver disease (NAFLD) is still not fully elucidated.
Patients with NAFLD have a low risk of liver complications, unless substantial liver fibrosis …

As it affects almost every third individual in the general population in the Western world, non-
alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver …

Non-alcoholic fatty liver disease (NAFLD) encompasses a variety of diseases ranging from
simple steatosis or fatty liver through non-alcoholic steatohepatisis (NASH) to fibrosis that …

Abstract Purpose of Review Patients with non-alcoholic fatty liver disease (NAFLD), often
considered as the hepatic manifestation of the metabolic syndrome, represent a population …

Overwhelming evidence suggests an association of cardiovascular disease (CVD) with non-
alcoholic fatty liver disease (NAFLD); however, the underlying mechanisms remain largely …

Abstract Purpose of Review The objective of this manuscript is to examine the current
literature on non-alcoholic fatty liver disease (NAFLD) biomarkers and their correlation with …

Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation
of fat in the liver associated with a range of metabolic disorders, such as obesity, insulin …